Zobrazeno 1 - 10
of 241
pro vyhledávání: '"HCV clearance"'
Autor:
Muhannad Abdullah Al-Azzawy
Publikováno v:
Al-Kitab Journal for Pure Sciences, Vol 3, Iss 2 (2022)
This study was conducted in Kirkuk city from June 2018 to March 2019. The number of hepatitis patient understudy were 40 newly diagnosed hepatitis C whose ages were between 20-75 years old. The purpose of this study was to evaluate the effect of inte
Externí odkaz:
https://doaj.org/article/a75b195c08dd45a49a47a0107ecd359e
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background To explore associations between PON1 rs854560, rs662, 705,379, HCV clearance, and interactions between tested PON1 single nucleotide variants (SNVs) and interferon-λ4 gene (IFNL4) rs368234815 variant in hemodialyzed individuals.
Externí odkaz:
https://doaj.org/article/69f4671e306f4f9d8f07ab446cd22aa3
Autor:
Daniel Sepúlveda-Crespo, María Belén Yélamos, Cristina Díez, Julián Gómez, Víctor Hontañón, Francisco Torresano-Felipe, Juan Berenguer, Juan González-García, Luis Ibañez-Samaniego, Elva Llop, Antonio Olveira, Javier Martínez, Salvador Resino, Isidoro Martínez
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 150, Iss , Pp 113024- (2022)
Objectives: The current study aimed to assess the impact of HIV on the production of anti-HCV antibodies in HCV-infected individuals with advanced HCV-related cirrhosis before and 36 weeks after the sustained virological response (SVR) induced by dir
Externí odkaz:
https://doaj.org/article/65e5a20bd52f47b08695f9860a591dbb
Autor:
Óscar Brochado, Isidoro Martínez, Juan Berenguer, Luz Medrano, Juan González-García, María Ángeles Jiménez-Sousa, Ana Carrero, Víctor Hontañón, Jordi Navarro, Josep M. Guardiola, Amanda Fernández-Rodríguez, Salvador Resino, the GESIDA Study Group
Publikováno v:
Journal of Biomedical Science, Vol 28, Iss 1, Pp 1-14 (2021)
Abstract Objective To evaluate the impact of hepatitis C virus (HCV) elimination via interferon (IFN)-based therapy on gene expression profiles related to the immune system in HIV/HCV-coinfected patients. Methods We conducted a prospective study in 2
Externí odkaz:
https://doaj.org/article/9ba9749c3585451b98a460fd99085b24
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Martinez-Roman, Paula, Crespo-Bermejo, Celia, Valle-Millares, Daniel, Lara-Aguilar, Violeta, Arca de Lafuente, Sonia, Martín-Carbonero, Luz, Ryan, Pablo, de Los Santos, Ignacio, Lopez-Huertas, Maria Rosa, Palladino, Claudia, Muñoz-Muñoz, María, Fernandez-Rodriguez, Amanda, Coiras, Mayte, Briz, Veronica, COVIHEP network
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 13; Pages: 3579
15 Pág.
Background: Although human immunodeficiency virus type 1 (HIV-1) reservoir size is very stable under antiretroviral therapy (ART), individuals exposed to the Hepatitis C virus (HCV) (chronically coinfected and spontaneous clarifiers) sh
Background: Although human immunodeficiency virus type 1 (HIV-1) reservoir size is very stable under antiretroviral therapy (ART), individuals exposed to the Hepatitis C virus (HCV) (chronically coinfected and spontaneous clarifiers) sh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8e9cf570fdb4254d27df049b568116f
https://hdl.handle.net/20.500.12105/15294
https://hdl.handle.net/20.500.12105/15294
Autor:
Mohamed Eltabbakh, Mohamed Abbasy, Mostafa Elhelbawy, Talaat Zakareya, Mohamed Deif, Hassan Ahmed Elzohry
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 2021 (2021)
Canadian Journal of Gastroenterology & Hepatology
Canadian Journal of Gastroenterology & Hepatology
Background/Objectives. Liver fibrosis is the inevitable end result of chronic hepatitis C (HCV) infection and is responsible for almost all liver-related complications. After the big advancement in therapeutics of HCV, liver fibrosis would expectedly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9ef093a60bbdb8ddb331fb0e185f196
https://doi.org/10.1155/2021/4961919
https://doi.org/10.1155/2021/4961919
Autor:
Maria Stella Franzè, Roberto Filomia, Gaia Caccamo, Concetta Pitrone, Angela Alibrandi, Carlo Saitta, Amalia Rita Caspanello, Clelia Asero, Vittoria Arcadi, Giovanni Raimondo, Irene Cacciola
Publikováno v:
Journal of Personalized Medicine; Volume 12; Issue 11; Pages: 1794
The predictive factors of long-term clinical benefits in patients with hepatitis C virus (HCV)—related liver cirrhosis after Direct Antiviral Agents (DAA) treatment are still undefined. The aim of this study was to identify any predictors of liver
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1913579126ab2fdfc4fe181fba5b8b86
https://pubmed.ncbi.nlm.nih.gov/36579534
https://pubmed.ncbi.nlm.nih.gov/36579534
Autor:
Ayat Gamal-AbdelNaser, Waleed S. Mohammed, Aisha Elsharkawy, Mohamed AbdAllah, Fatheya Zahran, Mahmoud ElHefnawi
Publikováno v:
Oral Diseases. 29:843-852
Objectives Chronic hepatitis C virus (HCV) infection is a debilitating disease that is lately treated using direct-acting antivirals (DAAs). Changes in the oral microbiome were detected in other liver diseases; however, oral microbiome was never inve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fd2d1e13a9bf418b934e0ca1ddc90b0
https://doi.org/10.1111/odi.14007
https://doi.org/10.1111/odi.14007
Publikováno v:
Public Health Genomics
Rising prices for new, transformative therapies are challenging health systems around the world, leading many payers and providers to begin rationing access to treatments, even in the countries that have been most resistant to doing so. This is the c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc1553a92f040b24af8f06811ac03dc5
https://doi.org/10.1159/000508141
https://doi.org/10.1159/000508141